President Trump announced the deal during a media briefing on Tuesday. Moderna is one of several companies manufacturing the vaccine “at risk,” as the industry calls it, meaning the company is currently making the vaccine before it is approved. Clinical trials are currently underway to test whether it’s safe and effective. Under this contract, worth… Read More »
Last week, Western intelligence officials pegged Russian hackers with an attempt to rip off leading research for a COVID-19 vaccine, linking the would-be thieves with the country’s intelligence services. Russia itself denies involvement in any of those attacks—and with a new licensing deal for AstraZeneca’s COVID-19 shot, the country says it doesn’t need the secrets… Read More »
Leading renewable energy consultancy and service provider, Natural Power, has acted as technical advisor to Greencoat Capital for its recent acquisition of Letteragh Wind Farm in the west of Ireland. David Dunne, Operations Manager at Natural Power Ireland and due diligence lead for the project said: “This project represents a further expansion of Greencoat Renewables’… Read More »
Welcome to the Running newsletter! Every Saturday morning, we email runners with news, advice and some motivation to help you get up and running. Sign up here to get it in your inbox. Dear Readers, Happy New Year, runners! Even if you’re like me and prefer to run outside, for a lot of us, gyms… Read More »
The mammoth consumer health deal Pfizer and GlaxoSmithKline struck last December is finally sealed. But things are looking markedly different at Pfizer than they did seven months ago—and that may not be a good thing, analysts say. Earlier this week, the New York drugmaker agreed to merge its off-patent drugs business, dubbed Upjohn, with Mylan,… Read More »